首页> 外文期刊>Journal of minimally invasive gynecology >Laparoscopic nerve-sparing radical vaginectomy in patients with vaginal carcinoma: surgical technique and operative outcomes.
【24h】

Laparoscopic nerve-sparing radical vaginectomy in patients with vaginal carcinoma: surgical technique and operative outcomes.

机译:腹腔镜保留神经的根治性阴道切除术在阴道癌患者中的应用:手术技术和手术效果。

获取原文
获取原文并翻译 | 示例
       

摘要

To describe our technique for laparoscopic nerve-sparing radical vaginectomy and to assess the feasibility and safety of the procedure via operative outcomes.Retrospective study (Canadian Task Force classification II-2).Major university teaching hospital in Chongqing, China.Twelve consecutive patients with early stage vaginal carcinoma.Laparoscopic radical parametrectomy/vaginectomy with pelvic/paraaortic lymphadenectomy.Nerve-sparing radical vaginectomy was completed laparoscopically without conversion to laparotomy in 12 patients with early stage vaginal cancer. Mean (SD) operative time was 158.5 (36.7) minutes, and estimated blood loss was 135.2 (62.8) mL. No intraoperative complications occurred, and no patients required blood transfusion. The number of pelvic nodes obtained was 21.2 (9.8), and of para-aortic nodes was 13. All nodes were negative for malignancy. Histologic analysis confirmed the absence of any residual cancer tissue in the margins of the parametrial tissue and vagina. The median (range) time before Foley catheter removal was 9.76 (3-14) days, and bladder void function recovery to grade 0-I was observed in 11 patients (91.7%). Neither long-term bladder voiding dysfunction nor any other long-term complications were reported. The median duration of follow-up was 28 months. One patient with stage II vaginal cancer received pelvic regional radiation therapy; the other patients did not require adjuvant therapy after the operation. All patients were included in the follow-up protocol, and there was no recurrence of disease in any patients.Laparoscopic radical parametrectomy/vaginectomy with pelvic/para-aortic lymphadenectomy is a therapeutic option for early stage vaginal carcinoma. Nerve-sparing radical surgery in indicated patients may lead to optimal preservation of bladder function. The technique described in this preliminary study seems to be safe and feasible, and was relatively easy to perform in our study population.
机译:回顾性研究(加拿大专责小组II-2级),中国重庆市某大学教学医院,连续12例患者接受了腹腔镜神经保留根治性阴道切除术,并通过手术结果评估了该方法的可行性和安全性。早期阴道癌。腹腔镜行根治性全子宫切除术/阴道切除术与盆腔/腹主动脉旁淋巴结切除术.12例早期阴道癌患者在腹腔镜下完成了保留神经的根治性阴道切除术,无需转换为剖腹手术。平均(SD)手术时间为158.5(36.7)分钟,估计失血量为135.2(62.8)mL。没有发生术中并发症,也没有患者需要输血。盆腔结节数为21.2(9.8),主动脉旁结节数为13。所有结节均为恶性。组织学分析证实在子宫旁膜组织和阴道的边缘不存在任何残留的癌组织。 Foley导管拔除前的中位时间为9.76(3-14)天,在11例患者中观察到膀胱空隙功能恢复至0-I级(91.7%)。没有长期的膀胱排尿功能障碍或任何其他长期并发症的报道。中位随访时间为28个月。 1例II期阴道癌患者接受了骨盆区域放疗;其余患者术后均不需要辅助治疗。所有患者均纳入随访方案,所有患者均无疾病复发。腹腔镜根治性全子宫切除/阴道切除联合盆腔/主动脉副淋巴结切除术是早期阴道癌的治疗选择。适应症患者的保留神经的根治性手术可能会导致膀胱功能的最佳保留。这项初步研究中描述的技术似乎是安全可行的,并且在我们的研究人群中相对容易实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号